Oculis intends to use the net proceeds from the Offering to advance and accelerate its clinical development pipeline, particularly the development of its novel neuroprotective clinical candidate ...

Staying on the right side of the European Union's online rulebook when it comes to the slippery topic of disinformation is ...

From new coordination methods to more transparency over lobbying, here’s how Ursula von der Leyen reshaped the Commission in ...

If you want to charge your electric car in public, you have to work your way through all kinds of pitfalls. What's going on ...